Dunn KE - Search Results

1

Production of thermostable phycocyanin in a mesophilic cyanobacterium.

Puzorjov A, Dunn KE, McCormick AJ. Puzorjov A, et al. Among authors: dunn ke. Metab Eng Commun. 2021 Jun 2;13:e00175. doi: 10.1016/j.mec.2021.e00175. eCollection 2021 Dec. Metab Eng Commun. 2021. PMID: 34168957 Free PMC article.

2

Using ultraviolet absorption spectroscopy to study nanoswitches based on non-canonical DNA structures.

McCarte B, Yeung OT, Speakman AJ, Elfick A, Dunn KE. McCarte B, et al. Among authors: dunn ke. Biochem Biophys Rep. 2022 Jun 4;31:101293. doi: 10.1016/j.bbrep.2022.101293. eCollection 2022 Sep. Biochem Biophys Rep. 2022. PMID: 35677630 Free PMC article.

3

The emerging science of electrosynbionics.

Dunn KE. Dunn KE. Bioinspir Biomim. 2020 Mar 11;15(3):033001. doi: 10.1088/1748-3190/ab654f. Bioinspir Biomim. 2020. PMID: 32160163

4

Face Coverings, Aerosol Dispersion and Mitigation of Virus Transmission Risk.

Viola IM, Peterson B, Pisetta G, Pavar G, Akhtar H, Menoloascina F, Mangano E, Dunn KE, Gabl R, Nila A, Molinari E, Cummins C, Thompson G, Lo TM, Denison FC, Digard P, Malik O, Dunn MJG, McDougall CM, Mehendale FV. Viola IM, et al. Among authors: dunn mjg, dunn ke. IEEE Open J Eng Med Biol. 2021 Jan 20;2:26-35. doi: 10.1109/OJEMB.2021.3053215. eCollection 2021. IEEE Open J Eng Med Biol. 2021. PMID: 34812420 Free PMC article.

5

Pain and withdrawal are common among patients receiving medications for opioid use disorder and associated with pain catastrophizing, negative affect, and poor sleep.

Berry MS, Dunn KE. Berry MS, et al. Among authors: dunn ke. Exp Clin Psychopharmacol. 2024 May 9. doi: 10.1037/pha0000723. Online ahead of print. Exp Clin Psychopharmacol. 2024. PMID: 38722586

6

Harm Reduction for Opioid Use Disorder: Strategies and Outcome Metrics.

Ellis JD, Dunn KE, Huhn AS. Ellis JD, et al. Among authors: dunn ke. Am J Psychiatry. 2024 May 1;181(5):372-380. doi: 10.1176/appi.ajp.20230918. Am J Psychiatry. 2024. PMID: 38706335 Review.

7

Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical population.

Bergeria CL, Park B, Satyavolu PU, Dunn KE, Dworkin RH, Strain EC. Bergeria CL, et al. Among authors: dunn ke. Front Psychiatry. 2024 Mar 11;15:1352300. doi: 10.3389/fpsyt.2024.1352300. eCollection 2024. Front Psychiatry. 2024. PMID: 38528975 Free PMC article.

8

The IMPOWR Network Divided or Single Exposure Study (DOSE) Protocol: A Randomized Controlled Comparison of Once Versus Split Dosing of Methadone for the Treatment of Comorbid Chronic Pain and Opioid Use Disorder.

McKendrick G, Davis W, Sklar M, Brown N, Pattillo E, Finan PH, Antoine D, Walters V, Dunn KE. McKendrick G, et al. Among authors: dunn ke. Subst Use Addctn J. 2024 Mar 25:29767342241239167. doi: 10.1177/29767342241239167. Online ahead of print. Subst Use Addctn J. 2024. PMID: 38528704

9

Establishing a research agenda for the study and assessment of opioid withdrawal.

Dunn KE, Strain EC. Dunn KE, et al. Lancet Psychiatry. 2024 Mar 20:S2215-0366(24)00068-3. doi: 10.1016/S2215-0366(24)00068-3. Online ahead of print. Lancet Psychiatry. 2024. PMID: 38521089 Review.

10

Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving Study.

Zamarripa CA, Spindle TR, Panlilio LV, Strickland JC, Feldman JD, Novak MD, Epstein DH, Dunn KE, McCurdy CR, Sharma A, Kuntz MA, Mukhopadhyay S, Raju KSR, Rogers JM, Smith KE. Zamarripa CA, et al. Among authors: dunn ke. Traffic Inj Prev. 2024;25(4):594-603. doi: 10.1080/15389588.2024.2327827. Epub 2024 Mar 18. Traffic Inj Prev. 2024. PMID: 38497810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page